Healthcare provider making initial contact prior to HLA-typing |
|
|
|
Transplant physician |
23 (40%) |
24 (41%) |
|
Other Physician |
15 (26%) |
17 (29) |
|
Transplant Specialist Nurse |
15 (26%) |
14 (24%) |
0.70 |
Other nurse |
2(3%) |
0 |
|
Non-clinical Admin |
3 (5%) |
3 (5%) |
|
|
Information supplied to donors pre HLA typing |
|
|
|
Verbal only |
26 (4%) |
34 (60%) |
|
Local written information |
31(53%) |
20 (35%) |
0.073 |
National written information |
1(2%) |
3(5%) |
|
|
RD heath assessment pre-HLA typing |
|
|
|
By written health questionnaire |
12 (21%) |
8 (14%) |
|
Health questionnaire over phone |
3 (5%) |
1 (2%) |
0.49 |
Verbal discussion open ended questions |
18 (32%) |
23 (40%) |
|
No assessment |
24 (42%) |
25 (44%) |
|
|
Willingness to donate is verified pre-HLA typing |
40 (69%) |
46 (79%) |
0.20 |
|
Individual to whom donor HLA results are first disclosed |
|
|
|
Donor |
22 (38%) |
9 (16%) |
0.007 |
Recipient |
10 (17%) |
15 (26%) |
|
Referring physician |
23 (40%) |
27 (47%) |
|
No consistent practice |
3 (5%) |
6 (11%) |
|
|
Background of the provider with ultimate responsibility for RD clearance |
|
|
|
Internist/GP |
1 (2%) |
0 |
|
Non-transplant hematologist |
29 (50%) |
18 (31%) |
0.036 |
Transplant physician |
26 (45%) |
40 (69%) |
|
Other |
2 (3%) |
0 |
|
|
Role of the physician providing donor clearance in the recipient's care |
|
|
|
Affiliated with transplant program with simultaneous responsibility for the recipient |
8 (14%) |
20 (35%) |
|
Affiliated with the transplant program and may be involved in the care of the recipient |
20 (34%) |
17 (30%) |
0.044 |
Affiliated with the transplant program but not involved in recipient's care |
19 (33%) |
15 (26%) |
|
Not involved in the transplant program or the recipient's care |
11 (19%) |
5 (9%) |
|
|
Existence of a written policy for RD care |
58 (98%) |
49 (83%) |
0.004 |
|
Written eligibility criteria exist for acceptance of RDs |
53 (93%) |
45 (78%) |
0.02 |
|
Source of eligibility criteria |
|
|
|
Locally written |
30 (53%) |
21 (36%) |
|
Based on NMDP criteria |
16 (28%) |
19 (33%) |
|
Based on WMDA criteria |
27 (48%) |
12 (21%) |
|
|
A health history questionnaire forms part of the assessment at donor medical |
52 (91%) |
41 (72%) |
0.008 |
|
There is a policy defining the limit for the number of apheresis procedures RDs may undergo for their initial donation |
39 (72%) |
31 (55%) |
0.057 |
|
Plerixa for has been used for mobilization of RDs |
|
|
|
Yes |
11 (20%) |
21 (38%) |
|
No |
38 (69%) |
34 (61%) |
0.032 |
Only in the context of a clinical trial |
6 (11%) |
1 (2%) |
|
|
BM harvests are performed by: |
|
|
|
Transplant physicians caring for the recipient |
43 (77%) |
41 (87%) |
|
Other transplant physicians or another team |
13 (23%) |
6(13%) |
0.36 |
|
There is a process for credentialing physicians performing BM harvests |
48 (86%) |
29 (63%) |
0.008 |
|
There is a policy defining the limit for the BM volume aspirated at harvest |
37 (66%) |
30 (65%) |
0.984 |
|
Long term (10 year) follow up is performed |
20 (34%) |
8 (14%) |
0.05 |